Consult the labeling of concomitantly used drug to obtain further information about interactions with PPIs.
![](https://mpfshstrg.blob.core.windows.net/mpf-uat-common-resources/Images/monograph/table.gif)
![](https://mpfshstrg.blob.core.windows.net/mpf-uat-common-resources/Images/monograph/table.gif)
IV: PREVACID I.V. is metabolized mainly by hepatic drug-metabolizing enzyme CYP2C19 and CYP3A4.
Gastric antisecretory effect of PREVACID I.V. may promote or inhibit absorption of concomitant drugs.
Contraindications for coadministration: (PREVACID I.V. should not be coadministered with the following drug.): See Table 9.
![](https://mpfshstrg.blob.core.windows.net/mpf-uat-common-resources/Images/monograph/table.gif)
Precautions for coadministration (PREVACID I.V. should be administered with care when coadministered with the following drugs.): See Table 10.
![](https://mpfshstrg.blob.core.windows.net/mpf-uat-common-resources/Images/monograph/table.gif)